Document and Entity Information
Document and Entity Information | Jun. 24, 2024 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jun. 24, 2024 |
Entity File Number | 001-37809 |
Entity Registrant Name | NEUROBO PHARMACEUTICALS, INC. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-2389984 |
Entity Address, Address Line One | 545 Concord Avenue |
Entity Address, Adress Line Two | Suite 210 |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02138 |
City Area Code | 857 |
Local Phone Number | 702-9600 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | NRBO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001638287 |
Amendment Flag | false |